Recombinant Rabbit monoclonal primary
Recombinant Phospho Erk1 (T202)+Erk2 (T185) Monoclonal Antibody (ET1603-22)
Synthetic phospho-peptide corresponding to residues surrounding thr185 of human erk2.
A549, NIH/3T3, MCF-7, human lung carcinoma tissue, human kidney tissue.
Store at +4C after thawing. Aliquot store at -20C or -80C. Avoid repeated freeze / thaw cycles.
1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Protein A affinity purified.
ERK 1 antibody; ERK 2 antibody; ERK-1 antibody; ERK-2 antibody; ERK1 antibody; erk1/2 antibody; ERK2 antibody; ERT1 antibody; ERT2 antibody; Extracellular signal regulated kinase 1 antibody; Extracellular signal-regulated kinase 1 antibody; Extracellular signal-regulated kinase 2 antibody; HS44KDAP antibody; HUMKER1A antibody; Insulin-stimulated MAP2 kinase antibody; MAP kinase 1 antibody; MAP kinase 2 antibody; MAP kinase 3 antibody; MAP kinase isoform p42 antibody; MAP kinase isoform p44 antibody; MAPK 1 antibody; MAPK 2 antibody; MAPK 3 antibody; Mapk1 antibody; MAPK2 antibody; MAPK3 antibody; Microtubule-associated protein 2 kinase antibody; Mitogen-activated protein kinase 1 antibody; Mitogen-activated protein kinase 2 antibody; Mitogen-activated protein kinase 3 antibody; MK01_HUMAN antibody; p38 antibody; p40 antibody; p41 antibody; p41mapk antibody; p42-MAPK antibody; P42MAPK antibody; p44-ERK1 antibody; p44-MAPK antibody; p44ERK1 antibody; p44MAPK antibody; PRKM 2 antibody; PRKM1 antibody; PRKM2 antibody; PRKM3 antibody; protein tyrosine kinase ERK2 antibody
Belongs to the protein kinase superfamily. CMGC Ser/Thr protein kinase family. MAP kinase subfamily.
Phosphorylated upon KIT and FLT3 signaling (By similarity). Dually phosphorylated on Thr-202 and Tyr-204, which activates the enzyme. Ligand-activated ALK induces tyrosine phosphorylation. Dephosphorylated by PTPRJ at Tyr-204.
Mitogen-activated protein kinases (MAPKs) are a widely conserved family of serine/threonine protein kinases involved in many cellular programs, such as cell proliferation, differentiation, motility, and death. The p44/42 MAPK (Erk1/2) signaling pathway can be activated in response to a diverse range of extracellular stimuli including mitogens, growth factors, and cytokines, and research investigators consider it an important target in the diagnosis and treatment of cancer. Upon stimulation, a sequential three-part protein kinase cascade is initiated, consisting of a MAP kinase kinase kinase (MAPKKK or MAP3K), a MAP kinase kinase (MAPKK or MAP2K), and a MAP kinase (MAPK). Multiple p44/42 MAP3Ks have been identified, including members of the Raf family, as well as Mos and Tpl2/COT. MEK1 and MEK2 are the primary MAPKKs in this pathway. MEK1 and MEK2 activate p44 and p42 through phosphorylation of activation loop residues Thr202/Tyr204 and Thr185/Tyr187, respectively. Several downstream targets of p44/42 have been identified, including p90RSK and the transcription factor Elk-1. p44/42 are negatively regulated by a family of dual-specificity (Thr/Tyr) MAPK phosphatases, known as DUSPs or MKPs, along with MEK inhibitors, such as U0126 and PD98059.